Health Trials

Cognitive Abnormality

3

Review clinical trials related to Cognitive Abnormality. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Interventions in Mathematics and Cognitive Skills

The purpose of this study is to investigate neurocognitive mechanisms underlying response to intervention aimed at enhancing, and remediating weaknesses in, numerical skills in children, including those with mathematical learning disabilities (MLD).

Participants needed: 180
Trial details
Age: 6-12Biological sex: AllType: InterventionalSponsor: Stanford UniversityUpdated: Jun 25, 2026Locations: 1
Eligibility criteria

Elementary school aged children starting from first grade (6-12 years old) [+5]

History of neurological or psychiatric disorder (i.e., schizophrenia, psychosis,... [+3]

Read more
Status: Not yet recruiting

Validity and Reliability of the Turkish Form of the Enjoyment of Physical Activity Scale-8 in Geriatrics With Minimal Cognitive Impairment

The main objective of this study is to examine the validity and reliability of the Turkish form of the Enjoyment of Physical Activity Scale-8 (PACES-8) in individuals aged 65 and over with Minimal Cognitive Impairment (MCI).

Participants needed: 100
Trial details
Age: 65+Biological sex: AllType: ObservationalSponsor: Istanbul University - CerrahpasaUpdated: May 18, 2026Locations: 1Duration: 1 Week
Eligibility criteria

Being 65 years of age or older, [+6]

Diagnosis of dementia or advanced cognitive impairment, [+4]

Read more
Status: Recruiting

Clinical Trial Protocol: Alzheimer's Dementia Underlying Encephalopathy

The goal of this clinical trial is to determine if utilizing the Quest AD-Detect blood test, while patient's are hospitalized for a cognitive diagnosis (such as delirium or encephalopathy), will result in an earlier diagnosis of underlying Alzheimer's disease. * Will this blood test have the ability to distinguish between Alzheimer's disease and other causes of cognitive impairment in the inpatient setting? * Neurology Clinic will complete a 6-month post-hospitalization follow up with patients who have had the Quest AD-Detect Alzheimer's Disease blood test completed while they were inpatient to discuss the risk assessment portfolio

Participants needed: 30
Trial details
Age: 60-90Biological sex: AllType: InterventionalSponsor: Covenant Health, USUpdated: Oct 29, 2025Locations: 6
Eligibility criteria

Ages 60 to 90 years old [+2]

Age under 60 years [+1]

Read more